ENT 100 Pill - yellow capsule/oblong, 18mm
Generic Name: entrectinib
Pill with imprint ENT 100 is Yellow, Capsule/Oblong and has been identified as Rozlytrek 100 mg. It is supplied by Genentech, Inc.
Rozlytrek is used in the treatment of Non Small Cell Lung Cancer; Solid Tumors and belongs to the drug class multikinase inhibitors. Rozlytrek 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ENT 100
Rozlytrek
- Generic Name
- entrectinib
- Imprint
- ENT 100
- Strength
- 100 mg
- Color
- Yellow
- Size
- 18.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Genentech, Inc.
- National Drug Code (NDC)
- 50242-0091
See also:
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Rybrevant
Rybrevant is used to treat certain types of non-small cell lung cancer (NSCLC) in adults. It is ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Tagrisso
Tagrisso (osimertinib) may be used to treat adults with non-small cell lung cancer (NSCLC) whose ...
Taxol
Taxol (paclitaxel) is used to treat breast cancer, lung cancer, and ovarian cancer. Includes Taxol ...
Abraxane
Abraxane is an antineoplastic medication used in the treatment breast cancer. Learn about side ...
More about Rozlytrek (entrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Imprints, shape & color data
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.